Provention Bio Reports First Quarter 2020 Financial Results and Provides Business Update

- Company on Track to Complete Submission of Rolling Biologics License Application for Teplizumab in Q4 2020 -

Thank you for visiting Tailwinds Research. We are pleased to offer free research on select small and micro cap companies. It is free to join and we hope you’ll take the time to do so.

To create an account please click on this link.

If you already have an account, please log in here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here